| Exeltis Suisse SA - Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg, Hartkapseln | | 68212 | | 01 | | Dutasterid-Tamsulosin Xiromed 0,5 mg/0,4 mg | | Hartkapseln | | G04CA52 | | Tamsulosin and Dutasteride | | 03.09.2021 | | |
| | Composition | | dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, Dutasterid-Weichkapsel innerhalb der Hartkapsel: propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, E 321, gelatina, E 171, glycerolum, triglycerida media, lecithinum ex soja, Tamsulosin-Pellets in Hartkapsel: acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, Kapselhülle: E 172 (nigrum), E 172 (rubrum), E 171, E 172 (flavum), gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Dutasteride | 0.5 mg | | Tamsulosine Hydrochloride | 0.4 mg correspond Tamsulosinum 0.367 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dutasteride | 0.5 mg | | Tamsulosine Hydrochloride | 0.4 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Acidi Methacrylici | | Tamsulosin-Pellets in Hartkapsel | | Ammoniae Solutio Concentrata | | | | Calcii Stearas | | | | Cellulosum Microcristallinum | | | | Dibutylis Sebacas | | | | E 171 | | color. | | E 172 | | color. | | E 321 | | | | Ethylis Acrylatis Polymerisatum cum Polysorbatum 80 | | | | Gelatina | | | | Glycerol | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lecithinum ex Soja | | | | Natrii Laurilsulfas | | | | Pro Capsula | | | | Propylenglycoli Monooctanoas | | Dutasterid-Weichkapsel innerhalb der Hartkapsel | | Propylenglycol | | | | Silica Colloidalis Hydrica | | | | Triglycerida Media | | |
| |
| |
|
